Logo of Idt Australia (ASX:IDT)Latest Idt Australia (ASX:IDT) News

Page 2
Page 2 of 2

IDT Australia Boosts Revenue 40.6% Amid Strategic Shift Despite Rising Losses

IDT Australia Limited reported a strong 40.6% increase in revenue to $19.86 million for FY25, driven by growth in advanced therapies and contract disbursements. However, the company’s net loss widened to $8.06 million as it transitions from its ‘Rebuild Strategy’ to a new phase focused on sustainable profitability.
Victor Sage
21 Aug 2025

IDT CEO Resigns Amid Revenue Surge and Rising Losses

IDT Australia announces the immediate resignation of CEO Paul McDonald, appointing Executive Chair Mark Simari to lead as the company reports a 40.6% revenue increase but a widening net loss for FY25.
Victor Sage
7 Aug 2025

IDT and Gelteq Forge New Gel-Based Manufacturing Frontier in Australia

IDT Australia has signed a memorandum with NASDAQ-listed Gelteq to establish a dedicated gel-based product manufacturing facility, marking a strategic expansion in pharmaceutical delivery technologies.
Victor Sage
17 July 2025

IDT Surges 30% in Quarterly Revenue, Backed by $62M in Proposals

IDT Australia reports a robust 30% jump in quarterly revenue to $4.1 million, driven by strong contract wins and a $62 million pipeline of open proposals, signaling sustained growth in pharmaceutical manufacturing.
Victor Sage
29 Apr 2025

IDT Australia Nearly Doubles Quarterly Revenue on Advanced Therapies Surge

IDT Australia reports a near doubling of quarterly revenue to $5.3 million, driven by explosive growth in its Advanced Therapies segment, with first-half revenue expected to jump 82%.
Victor Sage
28 Jan 2025

IDT Australia Secures $20M Loan to Fuel Pharmaceutical Growth

IDT Australia has finalized a $20 million asset-based loan facility with ScotPac, replacing its previous $4.7 million NAB facility, to support its expanding sales pipeline and recent contract wins.
Victor Sage
24 Jan 2025